Joint pain, tendon and ligament injuries, gut inflammation, digestive issues, post-surgery recovery GHK-Cu "The DNA Architect" Hair thats thinning, skin thats losing its firmness, and wounds or surface injuries that are slow to close
Research on rat models documents measurable reductions in pro-inflammatory cytokines (TNF-alpha and IL-6) following BPC-157 administration, limiting excessive tissue damage during recovery
Always consult with a healthcare provider to see if its the right option for your needs
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared BPC-157 for therapeutic use in humans or animals
However, the majority of research has been conducted in animals, and more comprehensive human studies are needed to establish its long-term safety
It originated from research involving protective compounds associated with the stomach and gastrointestinal tract